Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Abstract Text:

    t nakajimaT Nakajima,t kinoshitaT Kinoshita,a nashimotoA Nashimoto,m sairenjiM Sairenji,t yamaguchiT Yamaguchi,j sakamotoJ Sakamoto,t fujiyaT Fujiya,t inadaT Inada,m sasakoM Sasako,y ohashiY Ohashi, ,t nakajimaT Nakajima,t kinoshitaT Kinoshita,a nashimotoA Nashimoto,m sairenjiM Sairenji,t yamaguchiT Yamaguchi,j sakamotoJ Sakamoto,t fujiyaT Fujiya,t inadaT Inada,m sasakoM Sasako,y ohashiY Ohashi, ,t nakajimaT Nakajima,t kinoshitaT Kinoshita,a nashimotoA Nashimoto,m sairenjiM Sairenji,t yamaguchiT Yamaguchi,j sakamotoJ Sakamoto,t fujiyaT Fujiya,t inadaT Inada,m sasakoM Sasako,y ohashiY Ohashi, ,

    BACKGROUND: This prospective randomized study compared the survival of patients with tumour node metastasis (TNM) stage T2 N1-2 gastric cancer treated by gastrectomy alone or gastrectomy followed by uracil-tegafur. METHODS: Patients were randomly assigned to surgery alone or to surgery and postoperative uracil-tegafur 360 mg per m(2) per day orally for 16 months. The primary endpoint was overall survival. Relapse-free survival and site of recurrence were secondary endpoints. RESULTS: Of 190 registered patients, 95 were randomized to each group; two patients with early cancer were subsequently excluded from the chemotherapy group. The trial was terminated before the target number of patients was reached because accrual was slower than expected. Drug-related adverse effects were mild, with no treatment-related deaths. At a median follow-up of 6.2 years, overall and relapse-free survival rates were significantly higher in the chemotherapy group (hazard ratio for overall survival 0.48, P = 0.017; hazard ratio for relapse-free survival 0.44, P = 0.005), confirming the survival benefit shown in an interim analysis performed 2 years earlier. CONCLUSION: Interim and final analyses revealed a significant survival benefit for postoperative adjuvant chemotherapy with uracil-tegafur in patients with serosa-negative, node-positive gastric cancer. Registration number: NCT00152243 (http://www.clinicaltrials.gov).

    Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Publishing Authors By Initials

    t nakajimaT Nakajima,t kinoshitaT Kinoshita,a nashimotoA Nashimoto,m sairenjiM Sairenji,t yamaguchiT Yamaguchi,j sakamotoJ Sakamoto,t fujiyaT Fujiya,t inadaT Inada,m sasakoM Sasako,y ohashiY Ohashi, ,t nakajimaT Nakajima,t kinoshitaT Kinoshita,a nashimotoA Nashimoto,m sairenjiM Sairenji,t yamaguchiT Yamaguchi,j sakamotoJ Sakamoto,t fujiyaT Fujiya,t inadaT Inada,m sasakoM Sasako,y ohashiY Ohashi, ,t nakajimaT Nakajima,t kinoshitaT Kinoshita,a nashimotoA Nashimoto,m sairenjiM Sairenji,t yamaguchiT Yamaguchi,j sakamotoJ Sakamoto,t fujiyaT Fujiya,t inadaT Inada,m sasakoM Sasako,y ohashiY Ohashi, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The British journal of surgery

    VOLUME: 94

    Page Numbers: 1468-76

    Journal Abbreviation:

    ISSN: 1365-2168

    DAY: 22

    MONTH: Dec

    YEAR: 2007

    Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372553

    Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.

    AFFILIATION: Department of Gastrointestinal Surgery, Cancer Institute Hospital, Tokyo, Japan.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Br J Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News